These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

998 related articles for article (PubMed ID: 33044971)

  • 1. Maternal serum concentration of anti-Müllerian hormone is a better predictor than basal follicle stimulating hormone of successful blastocysts development during IVF treatment.
    Sadruddin S; Barnett B; Ku L; Havemann D; Mucowski S; Herrington R; Burggren W
    PLoS One; 2020; 15(10):e0239779. PubMed ID: 33044971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oocyte matched follicular fluid anti-Müllerian hormone is an excellent predictor of live birth after fresh single embryo transfer.
    Ciepiela P; Dulęba AJ; Kario A; Chełstowski K; Branecka-Woźniak D; Kurzawa R
    Hum Reprod; 2019 Nov; 34(11):2244-2253. PubMed ID: 31725884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discordant anti-müllerian hormone (AMH) and follicle stimulating hormone (FSH) among women undergoing in vitro fertilization (IVF): which one is the better predictor for live birth?
    Wang S; Zhang Y; Mensah V; Huber WJ; Huang YT; Alvero R
    J Ovarian Res; 2018 Jul; 11(1):60. PubMed ID: 30012195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
    Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
    Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diminished ovarian reserve and poor response to stimulation in patients <38 years old: a quantitative but not qualitative reduction in performance.
    Morin SJ; Patounakis G; Juneau CR; Neal SA; Scott RT; Seli E
    Hum Reprod; 2018 Aug; 33(8):1489-1498. PubMed ID: 30010882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AMH has no role in predicting oocyte quality in women with advanced age undergoing IVF/ICSI cycles.
    Dai X; Wang Y; Yang H; Gao T; Yu C; Cao F; Xia X; Wu J; Zhou X; Chen L
    Sci Rep; 2020 Nov; 10(1):19750. PubMed ID: 33184364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The predictive value of anti-Mullerian hormone on embryo quality, blastocyst development, and pregnancy rate following in vitro fertilization-embryo transfer (IVF-ET).
    Lin WQ; Yao LN; Zhang DX; Zhang W; Yang XJ; Yu R
    J Assist Reprod Genet; 2013 Jun; 30(5):649-55. PubMed ID: 23504440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antral follicle count determines poor ovarian response better than anti-Müllerian hormone but age is the only predictor for live birth in in vitro fertilization cycles.
    Mutlu MF; Erdem M; Erdem A; Yildiz S; Mutlu I; Arisoy O; Oktem M
    J Assist Reprod Genet; 2013 Jun; 30(5):657-65. PubMed ID: 23508679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Müllerian hormone serum values and ovarian reserve: can it predict a decrease in fertility after ovarian stimulation by ART cycles?
    Patrelli TS; Gizzo S; Sianesi N; Levati L; Pezzuto A; Ferrari B; Bacchi Modena A
    PLoS One; 2012; 7(9):e44571. PubMed ID: 22984527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimüllerian hormone as a predictor of good-quality supernumerary blastocyst cryopreservation among women with levels <1 ng/mL versus 1-4 ng/mL.
    Kavoussi SK; Odenwald KC; Boehnlein LM; Summers-Colquitt RB; Pool TB; Swain JE; Jones JM; Lindstrom MJ; Lebovic DI
    Fertil Steril; 2015 Sep; 104(3):633-6. PubMed ID: 26144573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients.
    Arce JC; La Marca A; Mirner Klein B; Nyboe Andersen A; Fleming R
    Fertil Steril; 2013 May; 99(6):1644-53. PubMed ID: 23394782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The addition of anti-Müllerian hormone in an algorithm for individualized hormone dosage did not improve the prediction of ovarian response-a randomized, controlled trial.
    Magnusson Å; Nilsson L; Oleröd G; Thurin-Kjellberg A; Bergh C
    Hum Reprod; 2017 Apr; 32(4):811-819. PubMed ID: 28175316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Müllerian hormone is correlated with cumulative live birth in minimal ovarian stimulation with clomiphene citrate: a retrospective cohort study.
    Ezoe K; Ni X; Kobayashi T; Kato K
    BMC Pregnancy Childbirth; 2020 Nov; 20(1):740. PubMed ID: 33246461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between follicular volume and oocyte competence, blastocyst development and live-birth rate: optimal follicle size for oocyte retrieval.
    Wirleitner B; Okhowat J; Vištejnová L; Králíčková M; Karlíková M; Vanderzwalmen P; Ectors F; Hradecký L; Schuff M; Murtinger M
    Ultrasound Obstet Gynecol; 2018 Jan; 51(1):118-125. PubMed ID: 29134715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte colony-stimulating factor priming improves embryos and pregnancy rate in patients with poor ovarian reserve: a randomized controlled trial.
    Jinno M; Tamaoka Y; Teruya K; Watanabe A; Hatakeyama N; Goda T; Kimata H; Jinno Y
    Reprod Biol Endocrinol; 2023 Mar; 21(1):29. PubMed ID: 36944952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delay in IVF treatment up to 180 days does not affect pregnancy outcomes in women with diminished ovarian reserve.
    Romanski PA; Bortoletto P; Rosenwaks Z; Schattman GL
    Hum Reprod; 2020 Jul; 35(7):1630-1636. PubMed ID: 32544225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of antral follicle count and serum anti-Müllerian hormone: Which is better for live birth prediction in patients aged over 40 with their first IVF treatment?
    Lee Y; Kim TH; Park JK; Eum JH; Lee HJ; Kim J; Lyu SW; Kim YS; Lee WS; Yoon TK
    Eur J Obstet Gynecol Reprod Biol; 2018 Feb; 221():151-155. PubMed ID: 29306180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of ovarian reserve markers in prediction of clinical pregnancy.
    Zebitay AG; Cetin O; Verit FF; Keskin S; Sakar MN; Karahuseyinoglu S; Ilhan G; Sahmay S
    J Obstet Gynaecol; 2017 May; 37(4):492-497. PubMed ID: 28421902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salpingectomy may decrease antral follicle count but not live birth rate for IVF-ET patients aged 35-39 years: a retrospective study.
    Chen T; Zhao F; Wang Q; Liu C; Lan Y; Wang S; Xin Z; Yang X
    J Ovarian Res; 2020 Jul; 13(1):80. PubMed ID: 32684158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Live birth rates after modified natural cycle compared with high-dose FSH stimulation using GnRH antagonists in poor responders.
    Lainas TG; Sfontouris IA; Venetis CA; Lainas GT; Zorzovilis IZ; Tarlatzis BC; Kolibianakis EM
    Hum Reprod; 2015 Oct; 30(10):2321-30. PubMed ID: 26307091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.